ulipristal viatris 30 mg comprimido recubierto con pelicula efg
viatris limited - ulipristal acetato - comprimido recubierto con pelÍcula - 30 mg - ulipristal acetato 30 mg - ulipristal
eslicarbazepina acetato aristo 800 mg comprimidos efg
aristo pharma gmbh - eslicarbazepina acetato - comprimido - 800 mg - eslicarbazepina acetato 800 mg - eslicarbazepina
eslicarbazepina acetato aristo 200 mg comprimidos efg
aristo pharma gmbh - eslicarbazepina acetato - comprimido - 200 mg - eslicarbazepina acetato 200 mg - eslicarbazepina
ganirelix gedeon richter
chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hormonas hipofisarias e hipotalámicas y análogos - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).
ulipristal aristo 30 mg comprimidos recubiertos con pelicula efg
aristo pharma gmbh - ulipristal acetato - comprimido recubierto con pelÍcula - 30 mg - ulipristal acetato 30 mg - ulipristal
abiraterona sandoz 500 mg comprimdos recubiertos con pelicula efg
sandoz farmaceutica s.a. - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona
abiraterona combix 500 mg comprimidos recubiertos con pelicula efg
laboratorios combix s.l.u. - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona
abiraterona cipla 500 mg comprimidos recubiertos con pelicula efg
cipla europe nv - abiraterona acetato - comprimido recubierto con pelÍcula - 500 mg - abiraterona acetato 500 mg - abiraterona
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegalia - hormonas hipofisarias e hipotalámicas y análogos - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasmas prostáticos - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.